Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression
- PMID: 25480462
- DOI: 10.1016/j.genhosppsych.2014.10.005
Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression
Abstract
Objective: Unexplained painful physical symptoms are commonly reported by depressed patients. The evidence suggests that dual-action antidepressants are potent in relieving pain in depression. However, a direct comparison of the effects of selective serotonergic and selective noradrenergic antidepressants on painful symptoms has not been investigated so far.
Method: Sixty patients who participated in the Genome-based Therapeutic Drugs for Depression study with a diagnosis of moderate or severe episodes of depression according to the International Classification of Diseases, 10th Revision, and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria were involved. All the participants were randomly allocated to receive nortriptyline or escitalopram. The severity of depression was measured using the Montgomery-Åsberg Depression Rating Scale, the Hamilton Depression Rating Scale and the Beck Depression Inventory at weeks 0, 2, 4, 6 and 8. The intensity of pain was measured on the Visual Analog Scale at the same points of the study.
Results: At "week 0," 83.3% of the patients later randomized to treatment with escitalopram and 86.7% of those treated with nortriptyline reported at least one painful symptom. A significant decrease of pain intensity was observed after 2 weeks of treatment. The two groups did not differ in degree of pain reduction at weeks 2, 4, 6 and 8 in comparison to baseline values. A 50% reduction in pain intensity preceded the 50% reduction of depression severity. The intensity of pain at "week 0" did not differ in remitted or nonremitted patients at week 8.
Conclusion: Both selective serotonergic and selective noradrenergic antidepressants are equally effective in alleviations of painful physical symptoms of depression. The presence of painful symptoms before the onset of treatment did not determine the final response.
Keywords: Escitalopram; Major depression; Nortriptyline; Pain.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.World J Biol Psychiatry. 2011 Oct;12(7):528-38. doi: 10.3109/15622975.2011.559270. Epub 2011 Mar 9. World J Biol Psychiatry. 2011. PMID: 21388237 Free PMC article. Clinical Trial.
-
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.Br J Psychiatry. 2009 Mar;194(3):252-9. doi: 10.1192/bjp.bp.108.057554. Br J Psychiatry. 2009. PMID: 19252156 Clinical Trial.
-
[Association between polymorphisms of ins/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients].Psychiatr Pol. 2008 Nov-Dec;42(6):903-14. Psychiatr Pol. 2008. PMID: 19441667 Clinical Trial. Polish.
-
Escitalopram : a review of its use in the management of major depressive and anxiety disorders.CNS Drugs. 2003;17(5):343-62. doi: 10.2165/00023210-200317050-00004. CNS Drugs. 2003. PMID: 12665392 Review.
-
[Escitalopram for treatment of major depressive disorder in adults].Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. doi: 10.1016/s0013-7006(05)82410-8. Encephale. 2005. PMID: 16389716 Review. French.
Cited by
-
Comparative Efficacy and Safety of Clonazepam versus Nortriptyline in Restless Leg Syndrome among Forty Plus Women: A Prospective, Open-Label Randomized Study.J Midlife Health. 2019 Oct-Dec;10(4):197-203. doi: 10.4103/jmh.JMH_26_18. J Midlife Health. 2019. PMID: 31942156 Free PMC article.
-
Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.Gut Microbes. 2021 Jan-Dec;13(1):1-16. doi: 10.1080/19490976.2020.1869501. Gut Microbes. 2021. PMID: 33535879 Free PMC article.
-
Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management.CNS Drugs. 2016 Apr;30(4):293-304. doi: 10.1007/s40263-016-0328-5. CNS Drugs. 2016. PMID: 27048351 Free PMC article. Review.
-
Therapeutic Basis of Clinical Pain Modulation.Clin Transl Sci. 2015 Dec;8(6):848-56. doi: 10.1111/cts.12282. Epub 2015 May 11. Clin Transl Sci. 2015. PMID: 25962969 Free PMC article. Review.
-
Remote Digital Measurement of Facial and Vocal Markers of Major Depressive Disorder Severity and Treatment Response: A Pilot Study.Front Digit Health. 2021 Mar 31;3:610006. doi: 10.3389/fdgth.2021.610006. eCollection 2021. Front Digit Health. 2021. PMID: 34713091 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical